5-112792506-C-T
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_000038.6(APC):c.706C>T(p.Gln236*) variant causes a stop gained change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_000038.6 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 29
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Familial adenomatous polyposis 1 Pathogenic:2
This variant is considered pathogenic. This variant creates a termination codon and is predicted to result in premature protein truncation. -
This sequence change creates a premature translational stop signal (p.Gln236*) in the APC gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in APC are known to be pathogenic (PMID: 17963004, 20685668). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with clinical features of familial adenomatous polyposis (PMID: 12007223). ClinVar contains an entry for this variant (Variation ID: 433612). For these reasons, this variant has been classified as Pathogenic. -
Carcinoma of colon Pathogenic:1
The p.Gln236X variant has been reported in the literature in 1/142 proband chromosomes of an individual from a FAP family; it was not found in any of the 100 control chromosomes evaluated (Gavert 2002). It was also reported in the InSiGHT Colon Cancer (x1) database. The variant leads to a premature stop codon at position 236 which is predicted to cause premature truncation or absent protein product and loss of function. Loss of function variants of the APC gene are an established disease mechanism in FAP. In summary, based on the above information, this variant is classified as pathogenic. -
Hereditary cancer-predisposing syndrome Pathogenic:1
The p.Q236* variant (also known as c.706C>T), located in coding exon 6 of the APC gene, results from a C to T substitution at nucleotide position 706. This changes the amino acid from a glutamine to a stop codon within coding exon 6. This mutation has been observed in an Israeli polyposis cohort and in 1/53 South Asian families with Familial Adenomatous Polyposis (Gavert N et al. Hum. Mutat., 2002 Jun;19:664; Khan N et al. Sci Rep, 2017 05;7:2214). In addition to the clinical data presented in the literature, this alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at